Balyasny Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $4.5M | Buy |
|
|||||
|
2022
Q3 | $387K | Buy |
|
|||||
|
2022
Q2 | $143K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $315K | Sell |
|
|||||
|
2021
Q3 | $3.58M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $342K | Sell |
|
|||||
|
2019
Q4 | $7.51M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.78M | Sell |
|
|||||
|
2018
Q2 | $3.82M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.96M | Sell |
|
|||||
|
2017
Q3 | $8.21M | Buy |
|
|||||
|
2017
Q2 | $13.8M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2.31M | Buy |
|
|||||
|
2016
Q3 | $2.34M | Buy |
|